BRCA2 and familial pancreatic carcinoma: Germline mutations associated with pancreatic cancer are ATM (2%–4%), BRCA1 (0%–1%), BRCA2 (8%–19%), CHEK2 (2%–9%), and PALB2 (3.1%–3.7%) (13).